Epidemiology of biopsy-proven giant cell arteritis (GCA) - PubMed (original) (raw)
Epidemiology of biopsy-proven giant cell arteritis (GCA)
E Nordborg et al. J Intern Med. 1990 Apr.
Abstract
During a 10-year period from 1st January 1977 to 31st December 1986, a temporal artery biopsy was performed in 2307 patients in the city of Göteborg. The biopsy revealed giant cell arteritis (GCA) in 284 (12.5%) of patients. The average annual incidence of biopsy-proven GCA was 6.7 per 100,000 inhabitants. For women and men it was 9.9 and 3.5 per 100,000 inhabitants, respectively. In individuals aged 50 years or older, the average incidence was 18.3 per 100,000 inhabitants, with values of 25 and 9.4 for women and men, respectively. The annual incidence rate increased significantly (P less than 0.01) for women, but not for men; this result was not explained by demographic changes in the population.
Similar articles
- Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.
González-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. González-Gay MA, et al. Ann Rheum Dis. 2001 Apr;60(4):367-71. doi: 10.1136/ard.60.4.367. Ann Rheum Dis. 2001. PMID: 11247867 Free PMC article. - Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
Mohammad AJ, Nilsson JÅ, Jacobsson LT, Merkel PA, Turesson C. Mohammad AJ, et al. Ann Rheum Dis. 2015 Jun;74(6):993-7. doi: 10.1136/annrheumdis-2013-204652. Epub 2014 Jan 17. Ann Rheum Dis. 2015. PMID: 24442881 - Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N, Mancuso P, Luberto F, Salvarani C. Catanoso M, et al. Arthritis Care Res (Hoboken). 2017 Mar;69(3):430-438. doi: 10.1002/acr.22942. Arthritis Care Res (Hoboken). 2017. PMID: 27214746 - Epidemiology of biopsy-positive giant cell arteritis: an overview.
Nordborg E. Nordborg E. Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S15-7. Clin Exp Rheumatol. 2000. PMID: 10948751 Review. - Giant cell arteritis: recent advances and guidelines for management.
Dasgupta B, Hassan N; British Society for Rheumatology Guidelines Group. Dasgupta B, et al. Clin Exp Rheumatol. 2007 Jan-Feb;25(1 Suppl 44):S62-5. Clin Exp Rheumatol. 2007. PMID: 17428372 Review.
Cited by
- Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.
Gabriel SE, Michaud K. Gabriel SE, et al. Arthritis Res Ther. 2009;11(3):229. doi: 10.1186/ar2669. Epub 2009 May 19. Arthritis Res Ther. 2009. PMID: 19519924 Free PMC article. Review. - Trends in the clinical presentation of temporal arteritis in Israel: reflection of increased physician awareness.
Nesher G, Rubinow A, Sonnenblick M. Nesher G, et al. Clin Rheumatol. 1996 Sep;15(5):483-5. doi: 10.1007/BF02229646. Clin Rheumatol. 1996. PMID: 8894362 - Giant cell arteritis.
Mason JC, Walport MJ. Mason JC, et al. BMJ. 1992 Jul 11;305(6845):68-9. doi: 10.1136/bmj.305.6845.68. BMJ. 1992. PMID: 1638247 Free PMC article. No abstract available. - Giant cell arteritis in Saudi Arabia.
Bosley TM, Riley FC. Bosley TM, et al. Int Ophthalmol. 1998;22(1):59-60. doi: 10.1023/a:1006167213695. Int Ophthalmol. 1998. PMID: 10090451 - Non-infectious orbital vasculitides.
Perumal B, Black EH, Levin F, Servat JJ. Perumal B, et al. Eye (Lond). 2012 May;26(5):630-9. doi: 10.1038/eye.2012.28. Epub 2012 Feb 24. Eye (Lond). 2012. PMID: 22361845 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical